Mino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetI won't diluteshareholdersHemorrhoidsis a $2BmarketAn actualiMSCupdateMino-Lokis our leadassetWe had aphase 2btrial with100%efficacyAnymentionof Mino-WrapOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023Only biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mMyron Holubiakand I founded aprivatecompany in2013I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetI won't diluteshareholdersHemorrhoidsis a $2BmarketAn actualiMSCupdateMino-Lokis our leadassetWe had aphase 2btrial with100%efficacyAnymentionof Mino-WrapOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023Only biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mMyron Holubiakand I founded aprivatecompany in2013I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoids

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Mino-Lok potential market >$1B
  2. Not many companies this size with 2 late stage assets
  3. I/ONTAK is our lead asset
  4. I won't dilute shareholders
  5. Hemorrhoids is a $2B market
  6. An actual iMSC update
  7. Mino-Lok is our lead asset
  8. We had a phase 2b trial with 100% efficacy
  9. Any mention of Mino-Wrap
  10. Our Halo-Lido trial will have final patient by end of 2022
  11. We have enough cash to go well into 2023
  12. Only biotech with 2 Myron's on the leadership team
  13. I/ONTAK was the best deal I ever made
  14. Insiders invested $26.5m
  15. I/ONTAK's potential market is >$300m
  16. Myron Holubiak and I founded a private company in 2013
  17. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  18. We expect to finish the Mino-Lok trial this year
  19. I'm a shareholder myself
  20. We will have exclusivity
  21. We will open up international sites for Mino-Lok trial
  22. We intend to submit a BLA in 2H 2022
  23. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  24. There are no FDA approved drugs to treat hemorrhoids